SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CYCLACEL PHARMACEUTICALS
(NQNM:CYCC Last Sale: 4.18 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (CYCC : $4.18) (CYCCP : $5.9)
$3,595 million Market Cap at Market Close, July 1, 2022
Employs 60.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
200 Connell Drive Research Report Earnings Snapshot - Last 08/12/18
Berkeley Heights, NJ 07922 Fact Sheet
Phone: 908-517-7330 Financial Statements
Peer Comparison
Annual Reports

Sir John Banham, Chmn., Spiro Rombotis, Pres./CEO, Paul McBarron, COO
Formerly, XCYTE THERAPIES INC of Seattle until merger with U.K.-based Cyclacel Group plc, March 28, 2006. Backed in part by Vulcan Ventures, the investment firm of Microsoft Corp. co-founder Paul Allen. IPO at $8 March 15, 2004. Raised $32 million, selling 4 million shares, 27% of the outstanding. Lead Manager: Piper Jaffray. Invitrogen Corporation paid $5 million for Xcyte's T cell expansion technology, the "Xcellerate Process," December 14, 2005.
Historical Charts    Technical Analysis
No Historical Data available for CYCC

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CYCC $4.18 $4.18 0 .0 $4.03 $4.24 703,170 $4.03 $4.24 859,998
Preferred CYCCP $5.9 $ 0 $0 $0 265 $6.48 $6.48 1,259
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $3,594,792
Preferred Stock $7,428
Total $3,602,220

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
28-MAR-06 XCYTD Symbol Changed to CYCC
28-MAR-06 XCYT Split 1 for 10
27-MAR-06 XCYT Symbol Changed to XCYTD
01-NOV-04 XCYTP Symbol Changed to XCYT
29-OCT-04 XCYT Symbol Changed to XCYTP

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex